12/27/2024
3:17 PM | Attar Eyal C. (Reporting)
Vor Biopharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/27/2024
8:05 AM | Vor Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/09/2024
6:39 AM | Vor Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
3:33 PM | Paradigm Biocapital Advisors LP (Filed by)
Vor Biopharma (Subject)
| Form SC 13G/A | |
11/08/2024
3:15 PM | ANG ROBERT (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2024
3:15 PM | Attar Eyal C. (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2024
3:15 PM | Quinlan Amy (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
11/08/2024
3:20 PM | Chakraborty Tirtha (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
3:15 PM | ANG ROBERT (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
3:15 PM | Attar Eyal C. (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
3:15 PM | Chakraborty Tirtha (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
3:15 PM | Quinlan Amy (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2024
3:16 PM | Choi Han Wook (Reporting)
Vor Biopharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/02/2024
3:17 PM | Choi Han Wook (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2024
6:05 AM | Vor Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/05/2024
3:06 PM | Vor Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/30/2024
3:01 PM | Vor Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
3:29 PM | Chakraborty Tirtha (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2024
3:30 PM | ANG ROBERT (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/19/2024
4:04 PM | Jorgensen Nathan D. (Reporting)
Vor Biopharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/26/2024
4:22 PM | Quinlan Amy (Reporting)
Vor Biopharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/04/2024
5:09 PM | Attar Eyal C. (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
3:38 PM | Attar Eyal C. (Reporting)
Vor Biopharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/28/2024
3:54 PM | Vor Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/28/2024
3:10 PM | Lundberg Sven Ante (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
3:10 PM | Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
3:10 PM | Patterson Matthew R (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
3:10 PM | Namouni Fouad (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2024
3:40 PM | Namouni Fouad (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2024
3:39 PM | Namouni Fouad (Reporting)
Vor Biopharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/09/2024
3:05 PM | Vor Biopharma (Filer)
| Form DEF 14A | |
04/09/2024
3:07 PM | Vor Biopharma (Filer)
| Form DEFA14A | |
04/09/2024
3:10 PM | Vor Biopharma (Filer)
| Form ARS | |
02/08/2024
4:10 PM | Attar Eyal C. (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
4:05 PM | Chakraborty Tirtha (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
4:06 PM | Jorgensen Nathan D. (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
4:08 PM | ANG ROBERT (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
6:38 PM | Attar Eyal C. (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
6:34 PM | Jorgensen Nathan D. (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
6:35 PM | ANG ROBERT (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
6:36 PM | Chakraborty Tirtha (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Kamala’s final humiliation (Ad) The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware of… yet have the potential to deliver colossal returns over the next four years.
I’m not talking about Tesla, Palantir, or anything else you’ve heard parroted by the mainstream financial press. No. These are Trump’s Secret Stocks.  It’s all waiting for you here. |
01/05/2024
4:03 PM | Vor Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
